Related Article

This CCR Translation refers to the following Article:
A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer
David S. Hong, Razelle Kurzrock, Yun Oh, Jennifer Wheler, Aung Naing, Les Brail, Sophie Callies, Val�rie Andr�, Sunil K. Kadam, Aejaz Nasir, Timothy R. Holzer, Funda Meric-Bernstam, Mayer Fishman, and George Simo